[A pan-cancer analysis of PYCR1 and its predictive value for chemotherapy and immunotherapy responses in bladder cancer].
High PYCR1 expression is an independent risk factor for poor prognosis in BLCA patients and can serve as a significant indicator for clinical decision-making as well as a marker for predicting sensitivity to chemotherapeutic agents and the efficacy of immunotherapy.
Authors
- Yutong Li (ORCID: https://orcid.org/0009-0002-5595-2853)
- Hongwei Liu (ORCID: https://orcid.org/0000-0001-7779-5807)
- Xuan Dong (ORCID: https://orcid.org/0000-0002-5853-2136)
- Rui Sun (ORCID: https://orcid.org/0000-0002-8484-8089)
- Xingyu Song
Institutions
- Guangdong Medical College (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-04-20
- DOI
- https://doi.org/10.12122/j.issn.1673-4254.2025.04.24
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article